Literature DB >> 17536251

Challenges in the anticipation of biosimilars: how must a P&T committee gear up?

Celynda Tadlock1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536251

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


× No keyword cloud information.
  2 in total

1.  Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-10

2.  Biosimilars: part 2: potential concerns and challenges for p&t committees.

Authors:  C Lee Ventola
Journal:  P T       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.